These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9855431)

  • 21. "Catch up" pertussis vaccine.
    Burgess MA
    Med J Aust; 1994 Jan; 160(1):44-5. PubMed ID: 8271990
    [No Abstract]   [Full Text] [Related]  

  • 22. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children.
    Glanz JM; McClure DL; Magid DJ; Daley MF; France EK; Salmon DA; Hambidge SJ
    Pediatrics; 2009 Jun; 123(6):1446-51. PubMed ID: 19482753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis in Newfoundland and Labrador: 1991-2004.
    Can Commun Dis Rep; 2005 Nov; 31(22):235-7. PubMed ID: 16669124
    [No Abstract]   [Full Text] [Related]  

  • 24. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
    Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
    Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.
    Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F
    Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pertussis. Current status and prevention].
    Bégué P
    Arch Fr Pediatr; 1993 Dec; 50(10):843-6. PubMed ID: 8053759
    [No Abstract]   [Full Text] [Related]  

  • 27. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
    Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
    Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
    Gardner P
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.
    Carlsson RM; Trollfors B
    Vaccine; 2009 Sep; 27(42):5709-18. PubMed ID: 19679218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
    Girard DZ
    Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against pertussis with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Lagergârd T; Robbins JB
    Biologicals; 1999 Jun; 27(2):89. PubMed ID: 10600190
    [No Abstract]   [Full Text] [Related]  

  • 36. [Genetic evolution under vaccine pressure: the Bordetella pertussis model].
    Simondon F; Guiso N
    Bull Soc Pathol Exot; 2000 Jul; 93(3):202-5. PubMed ID: 11030058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.
    Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G
    Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of postvaccinal response in children past pertussis].
    Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K
    Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Whooping cough: an emerging problem].
    Escorihuela Esteban R; Barajas Sánchez MV
    Rev Esp Salud Publica; 2002; 76(4):267-70. PubMed ID: 12216166
    [No Abstract]   [Full Text] [Related]  

  • 40. National consensus conference on pertussis, Toronto, May 25-28, 2002.
    Can Commun Dis Rep; 2003 Apr; 29 Suppl 3():1-33 (Eng), 1-36 (Fre). PubMed ID: 14558307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.